Microbot Medical Inc.
Market Cap
$125.77M
P/E Ratio
-6.13
EPS
$-0.45
Dividend Yield
0.00%
52-Week Range
$1.35 — $4.67
Volume
1.09M
Avg Volume
1.98M
Beta
1.23
P/E (TTM)
-6.13
Forward P/E
—
PEG Ratio
-0.37
P/S (TTM)
0.00
P/B (TTM)
1.65
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.37%
ROA (TTM)
-0.16%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.01
Current Ratio
27.53
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.20%
EPS Growth (5Y)
+0.12%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-0.35
EPS Est (Next Year)
$-0.34
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.67
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
45.57M
Float
45.55M
Free Float %
99.95%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
NASDAQ
IPO Date
1992-03-25
Employees
20
CEO
Harel Gadot
Index Membership
—
Website
https://www.microbotmedical.com
Microbot Medical Inc. (MBOT) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $125.77M, a P/E ratio of -6.13, MBOT is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MBOT against other stocks using dozens of fundamental and technical filters.
Microbot Medical Inc. (MBOT) has a trailing twelve-month (TTM) P/E ratio of -6.13. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Microbot Medical Inc. (MBOT) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Microbot Medical Inc. (MBOT) has a market capitalization of $125.77 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.